OTCMKTS:RDSMY - DSM Stock Price, Price Target & More

$26.59 +0.12 (+0.45 %)

(As of 04/23/2018 04:00 PM ET)

Previous Close$26.47

Today's Range$26.37 - $26.68

52-Week Range$17.7080 - $26.90

Volume27,625 shs

Average Volume79,177 shs

Market Capitalization$19.21 billion

P/E Ratio33.11

Dividend Yield1.54%

Beta1.31

About DSM (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. The company operates through three segments: Nutrition, Materials, and Innovation Center. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries; and food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for use in dairy, baking, beverage, and savory applications. The Materials segment provides Dyneema, a fiber solution serving textiles, commercial marine, and sports segments; high-performance plastics primarily for use in automotive and electronics markets, as well as offers solutions to specialized industries, including water management, breathable textiles, and flexible food packaging; and resins solutions for paints and coatings, fiber optic coatings, and 3D printing applications. The Innovation Center segment offers cellulosic bio-ethanol and bio-based succinic acids; anti-reflective coatings for solar glass; and anti-soiling coatings for use in cleaning and maintaining solar farms in desert-like conditions. This segment also produces biomedical materials and technologies that enable medical device manufacturers to enhance care across various medical specialties. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Receive RDSMY News and Ratings via Email

Sign-up to receive the latest news and ratings for RDSMY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Chemicals & allied products

Sub-IndustryN/A

SectorBasic Materials

SymbolOTCMKTS:RDSMY

CUSIPN/A

Webwww.dsm.com

Phone31-45-578-8111

Debt

Debt-to-Equity Ratio0.36%

Current Ratio2.44%

Quick Ratio1.61%

Price-To-Earnings

Trailing P/E Ratio33.11

Forward P/E Ratio20.14

P/E Growth2.08

Sales & Book Value

Annual Sales$9.76 billion

Price / Sales1.98

Cash Flow$3.5739 per share

Price / Cash7.44

Book Value$11.00 per share

Price / Book2.42

Profitability

EPS (Most Recent Fiscal Year)$0.80

Net Income$2.00 billion

Net Margins20.69%

Return on Equity9.43%

Return on Assets4.61%

Miscellaneous

Employees20,918

Outstanding Shares725,720,000

How to Become a New Pot Stock Millionaire

DSM (OTCMKTS:RDSMY) Frequently Asked Questions

What is DSM's stock symbol?

DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How were DSM's earnings last quarter?

DSM (OTCMKTS:RDSMY) released its quarterly earnings data on Wednesday, November, 5th. The basic materials company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.05. The basic materials company earned $2.90 billion during the quarter. DSM had a net margin of 20.69% and a return on equity of 9.43%. View DSM's Earnings History.

Who are some of DSM's key competitors?

Some companies that are related to DSM include Asahi Kasei (AHKSY), FMC (FMC), The Chemours (CC), Johnson Matthey (JMPLY), Huntsman (HUN), Olin (OLN), W. R. Grace and (GRA), Ashland (ASH), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP), KMG Chemicals (KMG), Nexeo Solutions (NXEO), OCI Partners (OCIP) and Innophos (IPHS).

Who are DSM's key executives?

DSM's management team includes the folowing people:

Mr. Feike Sijbesma, Chairman of the Managing Board & CEO (Age 59)
Ms. Geraldine Matchett, CFO & Member of the Managing Board (Age 46)
Mr. Dimitri de Vreeze, Member of the Managing Board (Age 51)
Dr. Robert W. van Leen, Chief Innovation Officer & Member of the Managing Board (Age 60)
Mr. Christoph G. Goppelsroeder, Pres & CEO of Nutritional Products and Member of the Managing Board (Age 59)

Has DSM been receiving favorable news coverage?

Headlines about RDSMY stock have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. DSM earned a coverage optimism score of 0.17 on Accern's scale. They also gave media stories about the basic materials company an impact score of 47.92 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $26.59.

How big of a company is DSM?

DSM has a market capitalization of $19.21 billion and generates $9.76 billion in revenue each year. The basic materials company earns $2.00 billion in net income (profit) each year or $0.80 on an earnings per share basis. DSM employs 20,918 workers across the globe.

How can I contact DSM?

DSM's mailing address is HET OVERLOON 1, HEERLEN P7, 6401 JH. The basic materials company can be reached via phone at 31-45-578-8111.

MarketBeat Community Rating for DSM (RDSMY)

Community Ranking:		2.7 out of 5 ( )
Outperform Votes:		59 (Vote Outperform)
Underperform Votes:		51 (Vote Underperform)
Total Votes:		110

MarketBeat's community ratings are surveys of what our community members think about DSM and other stocks. Vote "Outperform" if you believe RDSMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDSMY will underperform the S&P 500 over the long term. You may vote once every thirty days.

DSM (OTCMKTS:RDSMY) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for DSM in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.00	3.00	2.67	2.67
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

DSM (OTCMKTS:RDSMY) Consensus Price Target History

Price Target History for DSM (OTCMKTS:RDSMY)

DSM (OTCMKTS:RDSMY) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating
12/1/2017	Deutsche Bank	Upgrade	Hold -> Buy
3/28/2017	Liberum Capital	Upgrade	Hold -> Buy
3/9/2017	JPMorgan Chase	Upgrade	Underweight -> Neutral
1/6/2017	Barclays	Upgrade	Equal Weight -> Overweight

(Data available from 4/23/2016 forward)

DSM (OTCMKTS:RDSMY) Earnings History and Estimates Chart

Earnings by Quarter for DSM (OTCMKTS:RDSMY)

DSM (OTCMKTS:RDSMY) Earnings Estimates

2018 EPS Consensus Estimate: $1.72

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.55	$0.55	$0.55
Q2 2018	1	$0.51	$0.51	$0.51
Q3 2018	1	$0.36	$0.36	$0.36
Q4 2018	1	$0.30	$0.30	$0.30

DSM (OTCMKTS RDSMY) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Actual Revenue	Release Link	Conference Call
11/2/2017	Q3 2017	$0.29	$0.23	$2.5092 billion	View	N/A
8/1/2017	Q2 2017		$0.25	$2.3766 billion	View	N/A
2/15/2017	Q4 2016		$0.20	$2.1757 billion	View	N/A
11/6/2016	Q3 2016		$0.23	$2.2291 billion	View	N/A
8/3/2016	Q2 2016		$0.20	$2.2517 billion	View	N/A
4/26/2016	Q1 2016		$0.17	$2.1102 billion	View	N/A
2/17/2016	Q4 2015		$0.14	$2.1094 billion	View	N/A
11/3/2015	Q3 2015		$0.16	$2.3385 billion	View	N/A
8/4/2015	Q2 2015		$0.17	$2.7816 billion	View	N/A
4/29/2015	Q1 2015		$0.11	$2.6111 billion	View	N/A
2/11/2015			$0.14	$2.6885 billion	View	N/A
11/5/2014		$0.24	$0.29	$2.9017 billion	View	N/A
8/5/2014			$0.21	$3.0708 billion	View	N/A
5/6/2014	Q1 2014		$0.20	$3.1884 billion	View	N/A
2/26/2014			$0.16	$3.2664 billion	View	N/A
11/5/2013	Q3 2013		$0.21	$3.2422 billion	View	N/A
8/6/2013	Q2 2013	$0.21	$0.27	$3.2746 billion	View	N/A
5/2/2013	Q1 2013	$0.16	$0.23	$3.1262 billion	View	N/A
2/20/2013	Q4 2012	$0.16	$0.15		View	N/A
11/6/2012	Q3 2012		$0.15		View	N/A
8/7/2012	Q2 2012		$0.21		View	N/A
5/8/2012	Q1 2012		$0.28		View	N/A
2/29/2012	Q4 2011		$0.24		View	N/A
11/1/2011	Q3 2011		$0.33		View	N/A
8/2/2011	Q2 2011		$0.35		View	N/A
4/27/2011	Q1 2011		$0.32		View	N/A
2/23/2011	Q4 2010		$0.19		View	N/A
11/2/2010	Q3 2010		$0.24		View	N/A
4/28/2010	Q1 2010		$0.29		View	N/A
2/24/2010	Q4 2009		$0.72		View	N/A
4/28/2009	Q1 2009		$0.04		View	N/A
2/18/2009	Q4 2008		$0.54		View	N/A
10/27/2008	Q3 2008		$1.10		View	N/A
7/29/2008	Q2 2008		$0.45		View	N/A
2/13/2008	Q4 2007		$1.09		View	N/A

(Earnings results data provided by Zacks Investment Research)

DSM (OTCMKTS:RDSMY) Dividend Information

DSM pays an annual dividend of $0.41 per share, with a dividend yield of 1.54%. DSM pays out 51.25% of its earnings out as a dividend.

Annual Dividend:	$0.41
Dividend Yield:	1.54%
Payout Ratio:	51.25% (Trailing 12 Months of Earnings) 31.06% (Based on This Year's Estimates) 22.78% (Based on Next Year's Estimates)

Dividend Payments by Quarter for DSM (OTCMKTS:RDSMY)

DSM (OTCMKTS:RDSMY) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

DSM (OTCMKTS RDSMY) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.10%

Insider Trading History for DSM (OTCMKTS:RDSMY)

DSM (OTCMKTS RDSMY) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

DSM (OTCMKTS RDSMY) News Headlines

Source:

Date	Headline
	Contrasting DSM (RDSMY) & Its Peers www.americanbankingnews.com - April 21 at 11:12 AM
	DSM Opens New Seven-Acre Solar Field In Kingstree, South Carolina www.prnewswire.com - April 20 at 8:10 AM
	Does Koninklijke DSM NV.’s (AMS:DSM) PE Ratio Warrant A Buy? finance.yahoo.com - April 18 at 9:56 AM
	Jefferies Group Comments on DSM's Q1 2018 Earnings (RDSMY) www.americanbankingnews.com - April 16 at 1:17 AM
	BASF (BASFY) and DSM (RDSMY) Financial Contrast www.americanbankingnews.com - April 14 at 9:31 PM
	DSM - Repurchase of Shares (6 – 12 April 2018) www.prnewswire.com - April 13 at 3:33 AM
	[$$] DSM Lifts Outlook as Vitamins Boost Results finance.yahoo.com - April 12 at 10:51 AM
	DSM Announces Preliminary Q1 2018 Results and Increases Outlook www.prnewswire.com - April 12 at 1:21 AM
	Zacks Investment Research Downgrades DSM (RDSMY) to Hold www.americanbankingnews.com - April 8 at 5:55 PM
	DSM - Repurchase of Shares (3 - 5 April 2018) www.prnewswire.com - April 6 at 3:52 AM
	Financial Analysis: DSM (RDSMY) vs. Its Rivals www.americanbankingnews.com - April 5 at 3:02 PM
	DSM (RDSMY) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 4 at 1:52 PM
	New energyOrbit Marketplace Platform Streamlines Energy Efficiency and Customer Engagement for Utility Commercial & Industrial Customers www.prnewswire.com - April 4 at 7:34 AM
	Zacks Investment Research Lowers DSM (RDSMY) to Hold www.americanbankingnews.com - April 3 at 11:03 AM
	DSM (RDSMY) Stock Rating Upgraded by ValuEngine www.americanbankingnews.com - April 3 at 10:40 AM
	DSM - Repurchase of Shares (23 - 29 March 2018) www.prnewswire.com - March 30 at 4:52 AM
	What Do Analysts Think About Koninklijke DSM NV.’s (AMS:DSM) Growth? finance.yahoo.com - March 26 at 10:25 AM
	DSM - Repurchase of Shares (19 - 22 March 2018) finance.yahoo.com - March 23 at 9:47 AM
	DSM Announces Repurchase of Shares to Cover Share Based Compensation Plans and Stock Dividend www.prnewswire.com - March 19 at 3:36 AM
	DSM Publishes 2017 Integrated Annual Report finance.yahoo.com - March 9 at 10:54 AM
	Vitamin Maker DSM Reaps Soaring Sales From a Turn to Retail finance.yahoo.com - February 23 at 9:48 AM
	Koninklijke DSM (RDSMY) Given Average Recommendation of "Buy" by Brokerages www.americanbankingnews.com - February 14 at 12:12 PM
	DSM Reports 2017 Results finance.yahoo.com - February 14 at 8:53 AM
	Protectionism alone will not boost economy: Royal DSM CEO finance.yahoo.com - January 23 at 8:41 AM
	Koninklijke DSM (RDSMY) Given Consensus Recommendation of "Buy" by Analysts www.americanbankingnews.com - January 20 at 10:06 AM
	Koninklijke DSM (RDSMY) Raised to Buy at Zacks Investment Research www.americanbankingnews.com - January 7 at 10:32 PM
	DSM and Amyris Close Transactions for Brazilian Production Facility finance.yahoo.com - December 29 at 8:40 AM
	Koninklijke DSM (RDSMY) Given Average Rating of "Hold" by Analysts www.americanbankingnews.com - December 26 at 9:52 AM
	DSM Acquires BioCare Copenhagen to Expand Gut Health Ingredients Portfolio with Probiotics finance.yahoo.com - December 22 at 8:51 AM
	Koninklijke DSM (RDSMY) Stock Rating Lowered by ValuEngine www.americanbankingnews.com - December 2 at 7:42 PM
	Koninklijke DSM NV (RDSMY) Given Consensus Rating of "Buy" by Brokerages www.americanbankingnews.com - December 1 at 6:04 PM
	Koninklijke DSM (RDSMY) Upgraded at Deutsche Bank www.americanbankingnews.com - December 1 at 4:12 PM
	DSM - Repurchase of Shares (3-9 November 2017) finance.yahoo.com - November 12 at 12:12 PM
	Royal DSM (RDSMY) Q3 2017 Results - Earnings Call Transcript seekingalpha.com - November 5 at 6:58 AM
	DSM - Repurchase of Shares (6 October - 12 October 2017) finance.yahoo.com - October 13 at 8:35 AM
	DSM - Repurchase of Shares (22-28 September 2017) finance.yahoo.com - October 3 at 11:32 AM
	DSM - Repurchase of Shares (1-7 September 2017) finance.yahoo.com - September 15 at 8:04 AM
	DSM - Repurchase of Shares (1 - 7 September 2017) finance.yahoo.com - September 8 at 7:31 AM
	Here's Why Koninklijke DSM (RDSMY) Is a Good Investment Pick finance.yahoo.com - September 7 at 8:17 AM
	DSM Among Leaders in Dow Jones Sustainability World Index finance.yahoo.com - September 7 at 8:17 AM
	DSM - Repurchase of Shares (25 - 31 August 2017) finance.yahoo.com - September 1 at 7:54 AM
	DSM - Repurchase of Shares (14 - 17 August 2017) finance.yahoo.com - August 19 at 6:55 AM
	Royal DSM's (RDSMY) CEO Feike Sijbesma on Q2 2017 Results - Earnings Call Transcript seekingalpha.com - August 6 at 3:56 AM
	Healthy eating market growing in China: Royal DSM CEO finance.yahoo.com - July 18 at 7:46 AM
	Royal DSM CEO: Still hard to do business in China finance.yahoo.com - July 18 at 7:46 AM
	Royal DSM CEO urges companies to wise up to carbon pricin... finance.yahoo.com - July 18 at 7:46 AM
	DSM Finalizes Repurchase of Shares to Cover Existing Option Plans and Stock Dividends finance.yahoo.com - July 15 at 7:57 AM
	DSM - Repurchase of Shares (30 June - 6 July 2017) finance.yahoo.com - July 7 at 8:19 AM
	Erdogan Grip on Turkey to Tighten as He Retakes Ruling Party www.bloomberg.com - May 21 at 9:00 AM
	Chris Cornell’s Wife Disputes Suicide Ruling, Says Medication Could Have Played Role www.nbcnews.com - May 19 at 12:23 PM

DSM (OTCMKTS:RDSMY) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

DSM (OTCMKTS:RDSMY) Income Statement, Balance Sheet and Cash Flow Statement

DSM (OTCMKTS RDSMY) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff